Nasal irrigation for the prevention and treatment of upper respiratory tract infection by SARS-CoV-2: a narrative review.

IF 1.4 4区医学 Q4 INFECTIOUS DISEASES

Journal of Infection in Developing Countries Pub Date : 2024-09-30 DOI:10.3855/jidc.19234

Song Li, Xi-Cai Sun, Zhong-Fei Wu, Li Hu, Jing-Jing Wang, Min Yin, Lei Cheng, De-Hui Wang

{"title":"Nasal irrigation for the prevention and treatment of upper respiratory tract infection by SARS-CoV-2: a narrative review.","authors":"Song Li, Xi-Cai Sun, Zhong-Fei Wu, Li Hu, Jing-Jing Wang, Min Yin, Lei Cheng, De-Hui Wang","doi":"10.3855/jidc.19234","DOIUrl":null,"url":null,"abstract":"Introduction: The World Health Organization declared an end to the global emergency status of COVID-19 in May of 2023. However, the impact of COVID-19 is far from over. Individuals who have recovered from COVID-19 continue to experience physiological, psychological, or cognitive symptoms, such as fatigue, shortness of breath, dizziness, and loss of smell or taste, known as long COVID. This review aims to describe the clinical characteristics of the upper respiratory tract infection (URTI) caused by SARS-CoV-2, and provide evidence for the prevention and treatment of SARS-CoV-2 infection by using nasal irrigation. COVID-19 and nasal irrigation: Nasal irrigation presents a promising adjunct to standard COVID-19 prevention and treatment protocols. This practice is theorized to diminish viral presence in the upper respiratory tract, a region identified as a primary site for SARS-CoV-2 replication and shedding. By facilitating the removal of viral particles and enhancing mucociliary clearance, nasal irrigation could potentially lessen the severity of URTI symptoms and slow transmission rates. The review consolidates current evidence of the efficacy and safety of this approach across various populations, underscoring its practicality in both preventive and therapeutic contexts.Conclusions: We recommend that saline nasal irrigation is an effective, safe and convenient strategy to prevent the transmission of SARS-CoV-2 and alleviate the symptoms of URTI across various age groups.","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"18 9.1","pages":"S81-S91"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.19234","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The World Health Organization declared an end to the global emergency status of COVID-19 in May of 2023. However, the impact of COVID-19 is far from over. Individuals who have recovered from COVID-19 continue to experience physiological, psychological, or cognitive symptoms, such as fatigue, shortness of breath, dizziness, and loss of smell or taste, known as long COVID. This review aims to describe the clinical characteristics of the upper respiratory tract infection (URTI) caused by SARS-CoV-2, and provide evidence for the prevention and treatment of SARS-CoV-2 infection by using nasal irrigation. COVID-19 and nasal irrigation: Nasal irrigation presents a promising adjunct to standard COVID-19 prevention and treatment protocols. This practice is theorized to diminish viral presence in the upper respiratory tract, a region identified as a primary site for SARS-CoV-2 replication and shedding. By facilitating the removal of viral particles and enhancing mucociliary clearance, nasal irrigation could potentially lessen the severity of URTI symptoms and slow transmission rates. The review consolidates current evidence of the efficacy and safety of this approach across various populations, underscoring its practicality in both preventive and therapeutic contexts.

Conclusions: We recommend that saline nasal irrigation is an effective, safe and convenient strategy to prevent the transmission of SARS-CoV-2 and alleviate the symptoms of URTI across various age groups.

查看原文本刊更多论文

鼻腔冲洗用于预防和治疗 SARS-CoV-2 引起的上呼吸道感染：综述。

导言：世界卫生组织宣布 COVID-19 于 2023 年 5 月结束全球紧急状态。然而，COVID-19 的影响远未结束。从 COVID-19 中恢复过来的人仍会出现生理、心理或认知症状，如疲劳、气短、头晕、嗅觉或味觉丧失，即所谓的长 COVID。本综述旨在描述由 SARS-CoV-2 引起的上呼吸道感染（URTI）的临床特征，并为使用鼻腔冲洗预防和治疗 SARS-CoV-2 感染提供证据。COVID-19 和鼻腔冲洗：鼻腔冲洗是 COVID-19 标准预防和治疗方案的一个很有前景的辅助手段。据推测，这种方法可以减少上呼吸道中的病毒，而上呼吸道是 SARS-CoV-2 复制和脱落的主要部位。通过促进病毒颗粒的清除和提高粘膜的清除率，鼻腔冲洗有可能减轻上呼吸道感染症状的严重程度并降低传播率。本综述整合了目前这种方法在不同人群中的有效性和安全性证据，强调了这种方法在预防和治疗方面的实用性：我们建议，生理盐水鼻腔冲洗是预防 SARS-CoV-2 传播和减轻各年龄段尿道炎症状的一种有效、安全和方便的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection in Developing Countries INFECTIOUS DISEASES-

CiteScore

3.70

自引率

5.30%

发文量

239

审稿时长

4-8 weeks

期刊介绍： The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.